Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity. (Record no. 22106282)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01474 a2200409 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516112028.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201302s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1464-3391 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.bmc.2012.08.039 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Chen, Kuen-Feng |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20130214 |
| 245 00 - TITLE STATEMENT | |
| Title | Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Bioorganic & medicinal chemistry |
| Date of publication, distribution, etc. | Oct 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 6144-53 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Proliferation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Down-Regulation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ErbB Receptors |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Erlotinib Hydrochloride |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Phosphatase 2 |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| General subdivision | chemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quinazolines |
| General subdivision | chemical synthesis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Structure-Activity Relationship |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pao, Kuan-Chuan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Su, Jung-Chen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chou, Yi-Chieh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Chun-Yu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Hui-Ju |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huang, Jui-Wen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kim, InKi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shiau, Chung-Wai |
| 773 0# - HOST ITEM ENTRY | |
| Title | Bioorganic & medicinal chemistry |
| Related parts | vol. 20 |
| -- | no. 20 |
| -- | p. 6144-53 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.bmc.2012.08.039">https://doi.org/10.1016/j.bmc.2012.08.039</a> |
| Public note | Available from publisher's website |
No items available.